BILLERICA, Mass. & LONDON --(BUSINESS WIRE)--Jul. 2, 2018-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced as of July 1 , it has assumed direct commercial
Omnipod ® Horizon ™ System Significantly Improves Glycemic Control in Patients with Type 1 Diabetes BILLERICA, Mass. --(BUSINESS WIRE)--Jun. 24, 2018-- Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management
DASH System Features Sleek, Color Touch-Screen Handheld Personal Diabetes Manager, Bluetooth-Enabled, Waterproof 1 , Tubeless Pump and Suite of User-Friendly Mobile Applications No-Cost Personal Diabetes Manager with Purchase of Pods BILLERICA, Mass. --(BUSINESS WIRE)--Jun.
BILLERICA, Mass. --(BUSINESS WIRE)--May 29, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the William Blair & Company 38 th Annual Growth Stock
Increases Full Year 2018 Expected Revenue Growth to 22% to 25% on Strength in Global Omnipod; Introduces Second Quarter Expected Revenue Growth of 18% to 22% BILLERICA, Mass. --(BUSINESS WIRE)--May 3, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless
High-Caliber Team in Place Throughout Key Geographies Partnerships Established with Experienced European Companies for Customer Care and Logistics BILLERICA, Mass. & LONDON --(BUSINESS WIRE)--May 3, 2018-- Insulet Corporation (NASDAQ:PODD) ( Insulet or the Company), the leader in tubeless insulin
BILLERICA, Mass. & LONDON --(BUSINESS WIRE)--May 1, 2018-- Insulet Corporation (NASDAQ:PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that it has entered into partnerships with two
BILLERICA, Mass. --(BUSINESS WIRE)--Apr. 5, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the first quarter of 2018 on May
Strong Presence at National Professional Diabetes Congresses in the UK , France and Germany Demonstrates Insulet’s Commitment to the European Diabetes Community BILLERICA, Mass. --(BUSINESS WIRE)--Mar. 14, 2018-- Insulet Corporation (NASDAQ:PODD) ( Insulet or the Company), the leader in tubeless
BILLERICA, Mass. --(BUSINESS WIRE)--Feb. 28, 2018-- Insulet Corporation (NASDAQ:PODD) ( Insulet ), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming investor conferences: This press release
Full Year 2017 Revenue of $463.8 Million , Up 26%, and Gross Margin Up 230 Basis Points Full Year 2018 Expected Revenue Growth of 21% to 25% BILLERICA, Mass. --(BUSINESS WIRE)--Feb. 21, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump
Significant Presence at ATTD Congress Demonstrates Insulet’s Future Commitment to the Diabetes Community in Europe Studies Show Exceptional Potential for the Omnipod Horizon System to Maintain Stable Blood Glucose Levels after Specific Meal and Exercise Challenges BILLERICA, Mass.
BILLERICA, Mass. --(BUSINESS WIRE)--Jan. 29, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the fourth quarter and full year
